Abstract
AimsThe purpose of this study is to explore whether pre-treatment features of brain function can discriminate non-responders to antidepressant medication in the early phase.MethodsForty-four treatment-responsive depressed (RD) patients, 36 non-responsive depressed (NRD) patients, and 42 healthy controls (HCs) were recruited. Regional cerebral blood flow (CBF) and amplitude of low-frequency fluctuation (ALFF) values were calculated for all subjects. Correlation analyses were used to explore the relationship between symptom improvement and CBF/ALFF. Receiver operating characteristics (ROC) and the 10-fold cross-validation support vector machine (SVM) classifier were applied for the discrimination of treatment response.ResultsCompared with the HCs, the RD and NRD groups exhibited lower CBF and ALFF in the right posterior lobe of the cerebellum. Compared with the NRD group, the RD group showed distinct CBF patterns in the left frontal striatal regions and right frontal cerebellar regions, as well as distinct ALFF features in the left frontoparietal striatum and right frontotemporal striatal cerebellar regions. The ROC and SVM classifier revealed the optimal power to distinguish the RD and NRD groups based on the combined measures (i.e., CBF and ALFF).ConclusionDistinct features of CBF and ALFF in the frontal striatal network may serve as promising neuroimaging predictors for identifying patients with blunted responsiveness, which may facilitate personalized antidepressant treatment.
Highlights
Despite their importance for treating major depressive disorder (MDD), antidepressants can relieve only 22–50% of patients, and
We aimed to extend our previous research by predicting early treatment responsiveness [i.e., responsive depression (RD) or nonresponsive depression (NRD)] using discriminative cerebral blood flow (CBF) and amplitude of low-frequency fluctuation (ALFF) features and machine learning method
No significant differences in age, sex, or education levels were detected among the RD, NRD, and heathy controls (HCs) groups, and no significant differences in baseline severity of depression (i.e., Hamilton Depression Scale (HAMD) scores) were revealed between the RD and NRD groups (t = −0.477, P = 0.635)
Summary
Despite their importance for treating major depressive disorder (MDD), antidepressants can relieve only 22–50% of patients, and
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
